MAI Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,897
Closed -$1.38M 608
2019
Q3
$1.38M Sell
13,897
-749
-5% -$71.2K 0.06% 203
2019
Q2
$1.35M Buy
14,646
+9,950
+212% +$945K 0.06% 208
2019
Q1
$443K Sell
4,696
-117
-2% -$10.2K 0.02% 311
2018
Q4
$308K Sell
4,813
-361
-7% -$26.6K 0.02% 346
2018
Q3
$463K Sell
5,174
-82
-2% -$7.25K 0.02% 302
2018
Q2
$417K Sell
5,256
-650
-11% -$54K 0.02% 313
2018
Q1
$527K Sell
5,906
-796
-12% -$76.4K 0.03% 287
2017
Q4
$699K Buy
6,702
+155
+2% +$17.5K 0.04% 259
2017
Q3
$955K Hold
6,547
0.06% 204
2017
Q2
$850K Buy
6,547
+861
+15% +$105K 0.05% 221
2017
Q1
$708K Buy
5,686
+45
+0.8% +$5.38K 0.05% 236
2016
Q4
$653K Sell
5,641
-206
-4% -$22.9K 0.05% 231
2016
Q3
$611K Buy
5,847
+2,104
+56% +$228K 0.05% 247
2016
Q2
$369K Sell
3,743
-1,560
-29% -$161K 0.03% 299
2016
Q1
$531K Sell
5,303
-1,200
-18% -$124K 0.04% 263
2015
Q4
$779K Buy
6,503
+837
+15% +$96.8K 0.06% 212
2015
Q3
$613K Hold
5,666
0.05% 255
2015
Q2
$656K Hold
5,666
0.04% 262
2015
Q1
$653K Hold
5,666
0.04% 272
2014
Q4
$634K Buy
5,666
+520
+10% +$54.8K 0.04% 265
2014
Q3
$488K Hold
5,146
0.05% 249
2014
Q2
$442K Sell
5,146
-1,218
-19% -$92.6K 0.04% 248
2014
Q1
$444K Buy
6,364
+200
+3% +$15.8K 0.04% 248
2013
Q4
$521K Sell
6,164
-26
-0.4% -$2.06K 0.06% 219
2013
Q3
$477K Buy
6,190
+680
+12% +$47.7K 0.06% 201
2013
Q2
$322K Buy
+5,510
New +$332K 0.04% 234

Other funds holding CELG

MAI Capital Management's CELG Position: Q4 2019 in Review

MAI Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 13,897 shares — an estimated $1.38M sold.

MAI Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.38M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • MAI Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • MAI Capital Management sold 13,897 Celgene Corp shares in Q4 2019, an estimated $1.38M.
  • MAI Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • MAI Capital Management's Celgene Corp position peaked at $1.38M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on MAI Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.